University of California, Davis

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of California, Davis sits in the top decile of US sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count).

657 total trials 123 currently recruiting 435 completed early-phase tilt top decile by trial count

University of California, Davis: 657 sponsored US clinical trials, 123 recruiting.

University of California, Davis sponsors 657 registered US clinical trials on ClinicalTrials.gov, 123 of them currently recruiting, and 435 completed. 38 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 12 trials.

Top-decile sponsor footprint

University of California, Davis ranks in the top decile of sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 65/100

435 of 483 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

657 total, page 10 of 14

COMPLETED NA

Adhesive Strips in Dermatologic Surgery: Is Cosmetic Appearance Improved?

NCT01979497

COMPLETED Phase 1

Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

NCT01923337

COMPLETED NA

Can Whey Protein Improve Glycemic Control in Type 2 Diabetes?

NCT01925248

COMPLETED Phase 1

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

NCT02064036

COMPLETED Phase 4

Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART

NCT01869634

TERMINATED

Monitoring Growth of Preterm Infants

NCT01869153

COMPLETED NA

Intake-dependent Effect of Cocoa Flavanol Absorption, Metabolism and Excretion in Humans

NCT03201822

COMPLETED NA

Evaluation of Purse-String Closure Vs Second Intention

NCT02062866

COMPLETED NA

Training Doctors to Support Patient Self-Care of Depression

NCT01618552

COMPLETED NA

Intervention Effects of Intensity and Delivery Style for Toddlers With Autism

NCT02272192

COMPLETED

CTP Imaging of Lung Cancer

NCT01823094

COMPLETED

The Psychobiological Effects of Participation in a One-Month Insight Meditation Retreat

NCT03056105

COMPLETED Phase 2

Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer

NCT01676714

COMPLETED

Functional MRC With Eovist for Acute Cholecystitis

NCT02100358

COMPLETED NA

Effect of Small Daily Doses of B-carotene on Breast Milk Retinol

NCT01803659

COMPLETED NA

Cognitive Training for Fragile X Syndrome

NCT02747394

COMPLETED

Evaluation of Respiratory Heast Loss as a Physiologic Patient Monitor for Acute Care Medicine

NCT01808963

COMPLETED

Understanding Women's Contraceptive Expectations at the Time of a First Trimester Surgical Abortion

NCT01807715

COMPLETED NA

Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational Video

NCT02062853

COMPLETED NA

Effect of a Grape Seed Extract (GSE) on Insulin Resistance

NCT01889368

COMPLETED

Continuous Hemoglobin Evaluation

NCT01811342

COMPLETED

Thousand Asian American Study

NCT02596438

COMPLETED Phase 2

Induction Chemotherapy Followed by Chemoradiotherapy for Head and Neck Cancer

NCT01716195

COMPLETED Phase 1

Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

NCT01433965

COMPLETED NA

Bovine Milk Oligosaccharide Study

NCT01814540

COMPLETED NA

The Effects Grapes on Health Indices

NCT01674231

COMPLETED NA

Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) Metabolism

NCT01803594

COMPLETED NA

Use of Theater to Invoke Empathy and Reduce Bias in Medical Students

NCT01739257

COMPLETED NA

The Use of Microneedles in Photodynamic Therapy

NCT01812837

COMPLETED NA

Asthma and Indoor-air: Reducing Exposures

NCT01869543

COMPLETED

Perceptions of Aesthetic Outcomes of Zigzag and Linear Scars

NCT02115789

COMPLETED NA

Effect of Long Term Cocoa Flavanol Intake on Blood Pressure and Platelet Function in Healthy Adults, Part 2

NCT02447783

COMPLETED

Comparing Clinical Performance of Novice Trainee Endoscopists Using Conventional Air Insufflation Versus Warm Water Infusion Colonoscopy

NCT01482546

COMPLETED NA

Effect of Long Term Cocoa Flavanol Intake on Blood Pressure and Platelet Function in Healthy Adults, Part 1

NCT02447770

COMPLETED Phase 2

The Effects of California Strawberries on Parameters of Cardiovascular Health

NCT01705093

COMPLETED NA

Creating Smokefree Living Together for Chinese Household Pairs

NCT01592682

COMPLETED Phase 1

Effects of Resveratrol Supplements on Vascular Health in Postmenopausal Women

NCT01564381

COMPLETED NA

Use of Eye Exercises to Improve Vision

NCT03054597

COMPLETED NA

Utility of Abdominal Ultrasound in the Evaluation of Children With Blunt Trauma

NCT01540318

COMPLETED

Single Site Robotic Cholecystectomy in Non Selected Patients

NCT01855308

COMPLETED NA

Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved?

NCT01770002

COMPLETED NA

Randomized Controlled Trial Comparing Water vs. Air Method for Performing Colonoscopy in Adult Female Subjects

NCT01790425

COMPLETED NA

Set-back Suture Versus Traditional Vertical Mattress Suture

NCT01773447

COMPLETED

Markers of Atrial Fibrillation

NCT02734758

COMPLETED NA

Esophageal Echo Assessment of LV Function During Acute Normovolemic Hemodilution Using Crystalloid or Hypertonic Saline

NCT00683007

COMPLETED Phase 1

Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors

NCT01336842

COMPLETED NA

Niños Sanos, Familia Sana - A Multi-Intervention Program to Prevent Childhood Obesity in Mexican-Heritage Children in Rural California

NCT01900613

COMPLETED NA

Parent Specific Depression Education and Motivation

NCT01453790

COMPLETED Phase 1

Preventing Brain Injury in Infants With Congenital Heart Disease

NCT01426542

COMPLETED Early Phase 1

CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements

NCT01313910

← Previous Page 10 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 86
Phase 2 43
Phase 3 10
Phase 4 28

What is open in the University of California, Davis pipeline

123 recruiting of 657 indexed (19% open); 435 completed (66%).

Phase mix: 38 late (III/IV) vs 129 early (I/II) (early-phase heavy).

Top condition: Healthy (12 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of California, Davis: open-pipeline peers nationwide

Peers matched on 657 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 0%5%10%15%20%25% Total trials Recruiting share University of California, DavisVanderbilt University Medical CenterUniversity of RochesterUS Department of Veterans AffairsThe Cleveland ClinicEyePoint PharmaceuticalsHebrew SeniorLifeInsulet CorporationMedical University of South Carolina
University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 657 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this University of California, Davis page

657 registered trials is a research-attention snapshot, not an endorsement of University of California, Davis or any single study.

  • 123 of University of California, Davis's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Healthy is the condition University of California, Davis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Davis pipeline card: 657 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.